Sanofi
TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS
Last updated:
Abstract:
The present invention refers to lixisenatide for use in pediatrics.
Status:
Application
Type:
Utility
Filling date:
22 Sep 2020
Issue date:
24 Jun 2021